Autoantibodies against autologus tumor-associated antigens have been detected in the asymptomatic stage of cancer and can thus serve as biomar-kers for early cancer diagnosis. Moreover, because autoantibodies are found in sera, they can be screened easily using a noninvasive approach. Consequently, many studies have been initiated to identify novel autoanti-bodies relevant to various cancer types.